RNAi-Mediated Antiviral Screening System for the Conserved Domain of the Fowl Adenovirus Serotype 4 DNA Polymerase Gene
| Author | Ali Lotfivand | en |
| Author | Abdolkarim Zamani Moghadam | en |
| Author | Azam Mokhtari | en |
| Orcid | Ali Lotfivand [0009-0001-1397-8636] | en |
| Orcid | Abdolkarim Zamani Moghadam [0000-0002-4061-4942] | en |
| Orcid | Azam Mokhtari [0000-0003-0139-1456] | en |
| Accessioned Date | 2026-11-21T07:13:30Z | |
| Issued Date | 2026-06-30 | en |
| Abstract | Background: Fowl adenovirus serotype 4 (FAdV-4), a member of the family Adenoviridae and the genus Aviadenovirus, is the primary causative agent of hepatitis–hydropericardium syndrome (HHS) in poultry and causes substantial economic losses worldwide. Current control strategies, including biosecurity measures and vaccination, remain insufficient to fully prevent outbreaks, highlighting the need for novel antiviral approaches. RNA interference (RNAi)-based gene silencing represents a promising strategy; however, evaluating such antiviral molecules requires a stably maintained cell population that expresses essential viral genes. Objectives: This study aimed to develop a recombinant lentiviral vector encoding the conserved PHA02563 domain of the FAdV-4 DNA polymerase and generate a puromycin-selected chicken embryo kidney (CEK) cell population expressing this domain for future RNA interference (RNAi)-based antiviral screening. Methods: Chemically competent Escherichia coli Top10 cells were prepared and used for plasmid propagation. The lentiviral transfer plasmid pCDH-CMV-MCS-EF1-cGFP-T2A-Puro was transformed into competent bacteria and verified by agarose gel electrophoresis. The conserved 738 bp PHA02563 domain of the FAdV-4 DNA polymerase gene was excised from the donor plasmid pUC57-PHA02563 using the restriction enzymes EcoRI and BamHI. The pCDH backbone was digested with the same enzymes to generate compatible cohesive ends. The purified insert and linearized vector were ligated using T4 DNA ligase and transformed into competent Top10 cells. Recombinant clones were initially screened by colony PCR and restriction enzyme digestion, and successful insertions were verified by gel electrophoresis and sequencing. The confirmed recombinant plasmid was then used to generate lentiviral particles in HEK-293T cells using a third-generation packaging system. Subsequently, chicken embryo kidney (CEK) cells were transduced with these lentiviral vectors to achieve expression of the DNA polymerase PHA02563 domain. Biological replicates (n = 3) and technical replicates were included across all major experimental stages, including cloning, viral packaging, transduction, and RT-PCR analysis. Experimental units were clearly defined for each assay. Quantitative results are reported using the values available from the experimental records; when individual replicate-level values were unavailable for calculating a valid standard deviation, the observed values or ranges are reported rather than an estimated SD. Results: Recombinant clones carrying the 738 bp PHA02563 insert were confirmed by colony PCR, which yielded the expected 951 bp product; empty-vector controls yielded a 213 bp product, and the recombinant plasmid had the expected size of 8935 bp. Lentiviral particles were produced in HEK-293T cells, with functional titers of approximately 1.2 × 10⁷ to 4 × 10⁷ TU/mL across biological replicates. After chicken embryo kidney (CEK) cells were transduced at a multiplicity of infection of 0.5, GFP-positive cells reached approximately 85% at 48 h and 95% at 72 h. Following puromycin selection (0.8 μg/mL for 10 days), nontransduced control cells were completely eliminated, and the surviving CEK population stably maintained GFP expression. RT-PCR of the transduced cells yielded a single product of the expected 738 bp size, whereas untransduced cells and cells transduced with the scrambled control lentivector showed no amplification. Conclusions: A recombinant lentiviral construct expressing the conserved PHA02563 domain of FAdV-4 DNA polymerase was successfully constructed and confirmed by molecular analyses. In addition, a puromycin-selected chicken embryo kidney (CEK) cell population expressing the viral target gene was established. This platform provides a robust and reliable tool for future RNAi-based antiviral screening and functional studies of FAdV-4. | en |
| DOI | https://doi.org/10.5812/jjcmb-170752 | en |
| URI | https://brieflands.com/journals/jjcmb/articles/170752 | en |
| Keyword | Adenoviridae | en |
| Keyword | DNA-Directed DNA Polymerase | en |
| Keyword | Lentivirus | en |
| Keyword | Cloning, Molecular | en |
| Keyword | RNA Interference | en |
| Keyword | Transduction, Genetic | en |
| Publisher | Brieflands | en |
| Title | RNAi-Mediated Antiviral Screening System for the Conserved Domain of the Fowl Adenovirus Serotype 4 DNA Polymerase Gene | en |
| Type | Research Article | en |